Women with density in 75% or more of a mammogram are at almost five times the risk for breast cancer as women with density in less than 10%. This is largely because the disease is more difficult to detect, according to data from three nested case–control studies involving 1,112 matched case–control pairs. This makes density the third highest risk factor for breast cancer, behind age and mutations in BRCA1 or BRCA2.
Women with density in 75% or more of a mammogram are at almost five times the risk for breast cancer as women with density in less than 10%. This is largely because the disease is more difficult to detect, according to data from three nested case–control studies involving 1,112 matched case–control pairs. This makes density the third highest risk factor for breast cancer, behind age and mutations in BRCA1 or BRCA2.
The authors of the Canadian study calculated that the women with density in 75% or more of their mammogram had an odds ratio for developing breast cancer of 4.7 (95% CI, 3.0–7.4), whether detected by screening (OR 3.5; 95% CI, 2.0–6.2) or less than 12 months after a negative screening examination (OR 17.8; 95% CI, 4.8–65.9). And the increased risk persisted for at least 8 years, suggesting that masking is not the only force at work and that a biologic connection may exist between increased breast density and an increased risk for the disease.
Younger women were at greater risk than older; for those under 56 years of age, 26% of all breast cancers and half of those detected less than 1 year after a negative screen could be attributed to density in 50% or more of a mammogram.
Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-236.
Kerlikowske K. The mammogram that cried Wolfe. N Engl J Med. 2007;356:297-300.
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
AI helps improve detection of congenital heart defects on prenatal ultrasounds
January 31st 2025AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.
Read More